Selexipag: A New Treatment Agent for Pulmonary Arterial Hypertension

Journal Title: Meandros Medical and Dental Journal - Year 2019, Vol 20, Issue 1

Abstract

Pulmonary arterial hypertension (PAH) is a rare disease which is characterized by the progressive increase of pulmonary arterial pressure. PAH can lead to right cardiac insufficiency and death. Conventional and other treatment modalities that target the physiopathological and etiopathological causes of the disease are currently being used. Selexipag is an oral selective prostacyclin receptor agonist which was developed to overcome the pathophysiological mechanisms that play role in the PAH.

Authors and Affiliations

Onur Yazıcı, Hasan Güngör

Keywords

Related Articles

Retention and Deformation of Cobalt-Chromium and High-Impact Polyamide Clasps

Objective: The use of metal clasps especially in anterior region may cause aesthetic problems. Polyamide resin has been suggested as an alternative aesthetic denture clasp material. This study compared the retentive forc...

The Comparison of Different Surface Preparation Methods in Terms of Shear Bond Strength of Tri-ceram Porcelaintitanium Alloy

Objective: Several studies have been made to evaluate effects of the surface preparation on shear bond strength (SBS) of titanium-porcelain complex. However, a completed picture has not been obtained yet. Therefore, such...

Surgical Treatment of a Large Complex Odontoma

The treatment modalities for odontomas are generally depend on the tumors size. Small and medium lesions can usually be removed easily allowing preservation of surrounding anatomical structures. In our study, we reported...

The Comparison of Different Dimension Reduction and Classification Methods in Electroencephalogram Signals

Objective: Electroencephalogram (EEG) signals have been broadly utilized for the diagnosis of epilepsy. Expert physicians must monitor long-term EEG signals that is sometimes difficult and time consuming process for epil...

Loneliness and Social Isolation among Eldely People

Social isolation is defined as the process of people losing their contacts with other social resources or their willingness to participate. Social isolation is a grave and widespread problem among seniors in society caus...

Download PDF file
  • EP ID EP551003
  • DOI 10.4274/meandros.galenos.2017.20592
  • Views 104
  • Downloads 0

How To Cite

Onur Yazıcı, Hasan Güngör (2019). Selexipag: A New Treatment Agent for Pulmonary Arterial Hypertension. Meandros Medical and Dental Journal, 20(1), 1-6. https://europub.co.uk/articles/-A-551003